Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00506402
Status:
COMPLETED
Last Update Posted:
2009-05-05
First Post:
2007-07-24
Brief Title:
A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies
Sponsor:
CASI Pharmaceuticals Inc
Organization:
CASI Pharmaceuticals Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Agnogenic Myeloid Metaplasia |
| Hematological Malignancies |
| Myelodysplasia |
Keywords:
| Name | View |
|---|---|
| Adult patients with refractory leukemias MDS or AMM | View |